Measurement and Management of QT Interval Prolongation for General Physicians

被引:26
|
作者
Indraratna, Praveen [1 ,2 ,3 ]
Tardo, Daniel [4 ,5 ]
Delves, Madeline [6 ]
Szirt, Richard [2 ]
Ng, Ben [1 ,3 ]
机构
[1] Prince Wales Hosp, Dept Cardiol, Sydney, NSW 2031, Australia
[2] St George Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[4] St Vincents Hosp, Dept Med, Sydney, NSW, Australia
[5] Univ Notre Dame, Sch Med, Sydney, NSW, Australia
[6] Bloomfield Hosp, Dept Psychiat, Orange, NSW, Australia
关键词
torsades de pointes; QT interval; electrocardiogram; antipsychotics; antiarrhythmics; TORSADES-DE-POINTES; CLINICAL-PRACTICE GUIDELINES; NEW-ZEALAND COLLEGE; LONG-QT; RISK-ASSESSMENT; ECG ANALYSIS; HEART-RATE; CLARITHROMYCIN; SCHIZOPHRENIA; LEVOFLOXACIN;
D O I
10.1007/s11606-019-05477-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
One of the more challenging aspects of ECG interpretation is measurement and interpretation of the QT interval. This interval represents the time taken for the ventricles to completely repolarise after activation. Abnormal prolongation of the QT interval can lead to torsades de pointes, a form of potentially life-threatening polymorphic ventricular tachycardia (VT). Detection of a prolonged QT interval is essential as this can be a reversible problem, particularly in the context of the use of a variety of commonly prescribed medications in the hospital setting. Automated ECG printouts cannot be relied upon to diagnose QT interval prolongation; thus, the onus is on the clinician to identify it. This is a difficult task, as the normal QT interval is typically measured relative to the heart rate. Therefore, the QT interval often requires "correction" for the current heart rate, in order to correctly stratify the risk of torsades de pointes. A wealth of correctional formulae have been derived, but none has proven superior. We present an approach to the ECG in this context, and a step-by-step guide to manually measuring and correcting the QT interval, and an approach to management in common hospital-based clinical scenarios.
引用
收藏
页码:865 / 873
页数:9
相关论文
共 50 条
  • [31] Perioperative management of patients with congenital or acquired disorders of the QT interval
    O'Hare, M.
    Maldonado, Y.
    Munro, J.
    Ackerman, M. J.
    Ramakrishna, H.
    Sorajja, D.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (04) : 629 - 644
  • [32] Papaverine-induced QT Interval Prolongation and Ventricular Fibrillation in a Patient with a History of Drug-induced QT Prolongation
    Goto, Masayuki
    Sato, Masahito
    Kitazawa, Hitoshi
    Takahashi, Minoru
    Fuse, Koichi
    Saito, Atsushi
    Okabe, Masaaki
    Aizawa, Yoshifusa
    INTERNAL MEDICINE, 2014, 53 (15) : 1629 - 1631
  • [33] FACTORS RELATED TO QT INTERVAL PROLONGATION DURING PROBUCOL TREATMENT
    OHYA, Y
    KUMAMOTO, K
    ABE, I
    TSUBOTA, Y
    FUJISHIMA, M
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 45 (01) : 47 - 52
  • [34] Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
    Niemeijer, Maartje N.
    van den Berg, Marten E.
    Eijgelsheim, Mark
    Rijnbeek, Peter R.
    Stricker, Bruno H.
    DRUG SAFETY, 2015, 38 (10) : 855 - 867
  • [35] QT interval prolongation in a patient with LQT2 on levetiracetam
    Issa, Naoum P.
    Fisher, Westby G.
    Narayanan, Jaishree T.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 29 : 134 - 136
  • [36] QT interval prolongation by noncardiovascular drugs: A proposed assessment strategy
    Pourrias, B
    Porsolt, RD
    Lacroix, P
    DRUG DEVELOPMENT RESEARCH, 1999, 47 (02) : 55 - 62
  • [37] Relationship of mechanical dyssynchrony to QT interval prolongation in hypertrophic cardiomyopathy
    Badran, Hata Mahfouz
    Elnoamany, Mohamed Fahmy
    Soltan, Ghada
    Ezat, Mohamed
    Elsedi, Mohamed
    Abdelfatah, Raed Ahmed
    Yacoub, Magdi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2012, 13 (05) : 423 - 432
  • [38] QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics
    Chandrasekhar, Sanjay
    Fradley, Michael G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (07)
  • [39] The relationship between atypical antipsychotics drugs, QT interval prolongation, and torsades de pointes: implications for clinical use
    Diaz, Juan Carlos Ruiz
    Frenkel, Daniel
    Aronow, Wilbert S.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 559 - 564
  • [40] QT interval prolongation and torsade de pointes
    Patane, Salvatore
    Marte, Filippo
    Di Bella, Gianluca
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) : E51 - E53